Compositions for pre-surgical nutritional supplements
US-2024189256-A1 · Jun 13, 2024 · US
Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
US9119781B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9119781-B2 |
| Application number | US-201113703214-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 10, 2011 |
| Priority date | Jun 11, 2010 |
| Publication date | Sep 1, 2015 |
| Grant date | Sep 1, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a topical spray composition comprising a biologically active vitamin D derivative and a corticosteroid, and its use in the treatment of dermal diseases and conditions. The spray comprises especially a propellant selected from the group consisting of dimethyl ether, diethyl ether and methylethyl ether or a mixture thereof and further a pharmaceutically acceptable lipid carrier solubilised or suspended in said propellant.
First claim
Opening claim text (preview).
The invention claimed is: 1. A sprayable, storage stable, substantially anhydrous topical composition comprising a therapeutically effective amount of about 0.00001-0.05% w/w of calcipotriol or calcipotriol monohydrate and a therapeutically effective amount of about 0.0005-1% of a betamethasone ester, the calcipotriol or calcipotriol monohydrate and the betamethasone ester being dissolved in a propellant comprising dimethyl ether or a mixture of dimethyl ether and one or more…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9119781B2 cover?
- The present invention relates to a topical spray composition comprising a biologically active vitamin D derivative and a corticosteroid, and its use in the treatment of dermal diseases and conditions. The spray comprises especially a propellant selected from the group consisting of dimethyl ether, diethyl ether and methylethyl ether or a mixture thereof and further a pharmaceutically acceptable…
- Who is the assignee on this patent?
- Lind Marianne, Rasmussen Gritt, Sonne Mette Rydahl, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/593. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).